Oneness Biotech Co (LUX:ONEA) Cyclically Adjusted Book per Share: $10.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:ONEA Oneness Biotech Co Ltd LUX:ONEA
59 GF Score
Price $23.60
GF Value $35.65
! 4 Warning Signs
View Full Analysis

What is Oneness Biotech Co Cyclically Adjusted Book per Share?

Oneness Biotech Co LUX:ONEA 59 Cyclically Adjusted Book per Share is $10.00 as of Dec. 2025. GuruFocus rates LUX:ONEA with a GF Score™ of 59/100 and a GF Value™ of $35.65. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oneness Biotech Co's adjusted book value per share for the three months ended in Dec. 2025 was $3.438. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $10.00 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Oneness Biotech Co's average Cyclically Adjusted Book Growth Rate was 5.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Oneness Biotech Co was 20.50% per year. The lowest was 9.40% per year. And the median was 17.50% per year.

As of today (2026-07-17), Oneness Biotech Co's current stock price is $23.60. Oneness Biotech Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was $10.00. Oneness Biotech Co's Cyclically Adjusted PB Ratio of today is 2.36.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oneness Biotech Co was 31.55. The lowest was 1.73. And the median was 8.86.


Oneness Biotech Co  (LUX:ONEA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oneness Biotech Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.60/10.00
=2.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oneness Biotech Co was 31.55. The lowest was 1.73. And the median was 8.86.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oneness Biotech Co Cyclically Adjusted Book per Share Related Terms


Oneness Biotech Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Oneness Biotech Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oneness Biotech Co Cyclically Adjusted Book per Share Chart

Oneness Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 3.52 3.49 6.05 10.00

Oneness Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.05 8.32 8.65 8.07 10.00

LUX:ONEA vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Oneness Biotech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's Cyclically Adjusted PB Ratio falls into.


LUX:ONEA
59GF Score
Oneness Biotech Co Ltd LUX:ONEA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oneness Biotech Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oneness Biotech Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=3.438/324.0540*324.0540
=3.438

Current CPI (Dec. 2025) = 324.0540.

Oneness Biotech Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 1.772 238.132 2.411
201606 1.728 241.018 2.323
201609 1.757 241.428 2.358
201612 1.685 241.432 2.262
201703 1.688 243.801 2.244
201706 1.690 244.955 2.236
201709 1.686 246.819 2.214
201712 1.669 246.524 2.194
201803 1.655 249.554 2.149
201806 1.570 251.989 2.019
201809 1.411 252.439 1.811
201812 1.404 251.233 1.811
201903 1.437 254.202 1.832
201906 1.345 256.143 1.702
201909 2.498 256.759 3.153
201912 2.490 256.974 3.140
202003 2.407 258.115 3.022
202006 3.516 257.797 4.420
202009 3.731 260.280 4.645
202012 5.380 260.474 6.693
202103 5.452 264.877 6.670
202106 5.283 271.696 6.301
202109 5.105 274.310 6.031
202112 5.487 278.802 6.378
202203 5.384 287.504 6.068
202206 5.217 296.311 5.705
202209 5.281 296.808 5.766
202212 5.095 296.797 5.563
202303 5.074 301.836 5.447
202306 4.883 305.109 5.186
202309 4.662 307.789 4.908
202312 4.721 306.746 4.987
202403 4.557 312.332 4.728
202406 4.365 314.175 4.502
202409 4.286 315.301 4.405
202412 3.949 315.605 4.055
202503 3.669 319.799 3.718
202506 3.691 322.561 3.708
202509 3.610 324.800 3.602
202512 3.438 324.054 3.438

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $10.00 mean?
Oneness Biotech Co (LUX:ONEA) has a Cyclically Adjusted Book per Share of $10.00 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oneness Biotech Co and its competitors.
Is Oneness Biotech Co's Cyclically Adjusted Book per Share too high?
Oneness Biotech Co's current Cyclically Adjusted Book per Share is $10.00. Overall, Oneness Biotech Co has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Oneness Biotech Co's Cyclically Adjusted Book per Share of $10.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oneness Biotech Co and its competitors. Oneness Biotech Co's current Cyclically Adjusted Book per Share is $10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Oneness Biotech Co (LUX:ONEA) has a current Cyclically Adjusted Book per Share of $10.00. The stock's GF Value™ is $35.65, compared to a current price of $23.60 — trading 33.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is $10.00. Oneness Biotech Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Oneness Biotech Co (LUX:ONEA), the current Cyclically Adjusted Book per Share is $10.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oneness Biotech Co (LUX:ONEA) Overvalued in 2026?

Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued. The current stock price of $23.60 is trading 33.8% below its estimated GF Value™ of $35.65.

Key valuation signals for LUX:ONEA:

  • Cyclically Adjusted Book per Share: $10.00
  • GF Value™: $35.65 vs. price of $23.60 (33.8% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the LUX:ONEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oneness Biotech Co Business Description

Other Exchanges 4743:Taiwan
Address Zhongxiao West Road, No. 66, 35th Floor, Section 1, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
59GF Score

Get the complete analysis for LUX:ONEA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.60
Price
$35.65
GF Value